allogen marrow transplant patient chronic myeloid leukemia chronic phase random trial irradi regimen random trial regimen total bodi irradi patient chronic myeloid leukemia allogen marrow transplant chronic phase patient cyclophosphamid mg/kg total bodi irradi marrow hla-ident sibl cyclosporin methotrex prophylaxi acut graft-versus-host diseas fifty-seven patient Gy fraction irradi daili day Gy fraction day probabl relaps year Gy group Gy group actuari probabl surviv relapse-fre surviv year patient Gy Gy probabl transplant-rel mortal probabl moder acut graft-versus-host diseas Gy group Gy group relaps probabl patient dose total bodi irradi improv surviv mortal relaps 